Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2], Ali Akram, M.B.B.S.[3], Anmol Pitliya, M.B.B.S. M.D.[4]
Synonyms and keywords: Immune deficiency; immunity suppression; immunological deficiency; immunosuppression
Overview
Classification
| | | | | | | | | | | | | | | | Immunodeficiency | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Immunodeficiency affecting cellular and humoral Immunity | | Combined immunodeficiency | | Predominantly antibody deficiency | | Diseases of immune dysregulation | | Congenital defects of phagocytes | | Defects in intrinsic and innate immunity | | Auto-imflammatory disorders | | Complement deficiencies | | Phenocopies of primary immunodeficiency (PID) | |
Immunodeficiency Affecting Cellular and Humoral Immunity
| | | | | | | | | Immunodeficiency affecting cellular and humoral immunity | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | CD19 NL: SCID T-ve B+ve | | | | | | | | CD19 ↓: SCID T-ve B-ve | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| SCID T-ve B+ve NK-ve | | | | SCID T-ve B+ve NK+ve | | SCID T-ve B-ve NK-ve | | | | SCID T-ve B-ve NK+ve | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | |
| | | yc deficiency | | | | | IL7Ra . | | | ADA def | | Microcephaly present | | | Microcephaly absent | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | JAK-3 def | | | | | CD3D, CD3E, CD247 | | | Reticular dysgenesis | | | | DNA Ligase IV def | | | | RAG1/2 def | |
| | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | CD45 def | | | | | | | | XLF def | | | | DCLRE1C def | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | Coronin-1A def | | | | | | | | DNA PKcs def | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | Winged helix def | | | | | | | | | | | | | | | |
|
Combined Immunodeficiency
| | | | | | | | | | | | | | | | | | | | | | | | | | Combined Immunodeficiency Diseases with associated or syndromic features | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Congenital thromocytopenia | | | | | DNA Repair Defects | | | | Immuno-osseous dysplasias | | | | Thymic Defects with additional congenital anomalies | | | Hyper-IgE syndromes(HIES) | | | Dyskeratosis congenita (DKC) | | | Defects of Vitamin B12 and Folate metabolism | | | Anhidrotic Ectodermodysplasia with ID | | | Others | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Wiskott Aldrich Syndrome | | | | | | Ataxia telangiectasia | | | | | Cartilage Hair Hypoplasia | | | | | DiDeorge Syndrome | | | | Job Syndrome | | | | Dyskeratosis congenita | | | | Transcobalmin 2 deficiency | | | | NEMO deficiency | | | | Purine nucleoside phosphorylase deficiency | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | XL thrombocytopenia | | | | | | Nijmegen breakage Syndrome | | | | | Schimke Syndrome | | | | | TBX1 deficiency | | | | Comel Netherton Syndrome | | | | COATS plus syndrome | | | | Deficiency causing hereditary folate malabsorption | | | | EDA-ID due to IKBA GOF mutation | | | | ID with multiple intestinal atresias | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | WIP deficiency | | | | | | Bloom syndrome | | | | | MYSM1 deficiency | | | | | Chromosome 10p13-p14 deletion Syndrome | | | | PGM3 deficiency | | | | SAMD9 | | | | Methylene-tetrahydrofolate-dehydrogenase 1 deficiency | | | | | | | | | Hepatic veno-occlusive disease with immunodeficiency | | | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | ARPC1B deficiency | | | | | | PMS2 deficiency | | | | | MOPD1 deficiency | | | | | {{{ F04 }}} | | | | | | | | | SAMD9L | | | | | | | | | | | | | | Vici Syndrome | | | | | | | | | |
| | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | Immunodeficiency with centromeric instability and facial anomalies(ICF1, ICF2, ICF3, ICF4) | | | | | EXTL3 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | HOIL1 deficiency, HOIP1 deficiency | | | | | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | MCM4 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Calcium Channel Defects(ORAI-1 deficiency, STIM1 deficiency) | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | RNF168 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Hennekam-lymphangiectasia-lymphedema syndrome | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | POLE1 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | STAT5b deficiency | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | POLE2 deficiency | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Kabuki Syndrome | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | NSMCE3 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | ERCC6L2(Hebo deficiency) | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | Ligase 1 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | GINS1 deficiency | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Predominantly Antibody Deficiency
| | | | | | Predominantly Antibody deficiencies, a: Hypogammaglobulinemia | | |
| | | | | | | | | | | | |
| | | | | | Serum immunoglobulin assays : IgG, IgA, IgM, IgE | | |
| | | | | | | | | | | | |
| | | | | | IgG, IgA, and/or IgM ↓↓
→ B Lymphocyte (CD19+) enumeration (CMF) | |
| | | | | | | | | | | | | | | |
| | | | | | | | | |
| B absent | | | | | | B >1% | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | X-Linked Agammaglobulinemia | | Common Variable Immunodeficiency Phenotype | | | | CD19 deficiency | |
|
| | | | | | | | | | | | | | | | | | |
| | | µ heavy chain Def | | | | CVID with no gene defect specified | | CD20 deficiency | |
| |
| | | | | | | | | | | | | | | | | | |
| | | Igα def | | | | PIK3CD mutation(GOF),PIK3R1 deficiency(LOF) | | CD21 deficiency | |
| |
| | | | | | | | | | | | | | | | | |
| | | Igβ def | | | | PTEN deficiency(LOF) | | TRNT1 deficiency | | |
| |
| | | | | | | | | | | | | | | | | | |
| | | BLNK def | | | | CD81 deficiency | | NFKB1 deficiency | |
| |
| | | | | | | | | | | | | | | | | | |
| | | λ5 def | | | | TACI deficiency | | NFKB2 deficiency | | |
| |
| | | | | | | | | | | | | | | | | | |
| | | PI3KR1 def | | | | BAFF receptor deficiency | | IKAROS deficiency | |
| |
| | | | | | | | | | | | | | | | | | |
| | | E47 transcription factor def | | | | TWEAK deficiency | | ATP6AP1 deficiency | |
| |
| | | | | | | | | | | |
| | | | | | | | Mannosyl-oligosaccharide glucosidase deficiency (MOGS) | |
|
| | | | | | | | | | | | |
| | | | | | | | TTC37 deficiency | | |
|
| | | | | | | | | | |
| | | | | | | | IRF2BP2 deficiency | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Predominantly Antibody deficiencies. b:Other antibody deficiencies | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Serum Immunolobulin Assays: IgG, IgA, IgM, IgE | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | Severe Reduction in Serum IgG and IgA with NI/elevated IgM and Normal Numbers of B cells: Hyper IgM Syndromes | | | | | Isotype, Light Chain, or Functional Deficiencies with Generally NI Numbers of B cells | | | | High B cell numbers due to constitutive NF-kB activation | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | AID deficiency | | | | | | Selective IgA deficiency | | | | | CARD11 Gain of Function | | | | | | | | | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | UNG deficiency | | | | | | Transient hypogammaglobuliemia of infancy | | | | | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | INO80 | | | | | | IgG subclass deficiency with IgA deficiency | | | | | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | MSH6 | | | | | | Isolated IgG subclass deficiency | | | | | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | Specific antibody deficiency with normal Ig levels and normal B cells | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | Ig heavy chain muations and deletions | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | Kappa chain deficiency | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | Selective IgM deficiency | | | | | | | | | | | | | | | |
|
Diseases of Immune Dysregulation
Congenital Defects of Phagocytes
Defects in Intrinsic and Innate Immunity
Auto-imflammatory Disorders
Complement Deficiencies
Phenocopies of Primary Immunodeficiency (PID)
| | | | Phenocopies of PID | | | | |
| | | | | | | | | | | | | | |
| | | | | | | |
| Associated with Somatic Mutations | | | | | Associated with Auto-Antibodies | | |
| | | | | | | | | | | | | | | |
| | | ALPS-SFAS | | | | | | Chronic mucocutaneous candidiasis | |
| |
| | | | | | | | | | | | | | | |
| | | RALD(RAS-associated autoimmune leukoproliferative disease) | | | | | | Adult-onset immunodeficiency with susceptibility to mycobacteria | |
| |
| | | | | | | | | | | | | | | |
| | | Cryopyrinopathy(Muckle-Wells Syndrome) | | | | | | Recurrentt skin infections | |
| |
| | | | | | | | | | | | | | | | |
| | | Hypereosinophilic syndrome due to somatic mutations in STAT5b | | | | | | Pulmonary alveolar proteinosis | | |
| |
| | | | | | | | | | | | | | | |
| | | | | | | | | | Acquired angiooedema | | |
|
| | | | | | | | | | | | | | | |
| | | | | | | | | | Atypical Hemolytic Uremic Syndrome | | |
|
| | | | | | | | | | | | | | | |
| | | | | | | | | | Thymoma with hypogammaglobulinemia | | |
|
References
ca:Immunodeficiència
de:Immundefekt
el:Ανοσολογική ανεπάρκεια
he:כשל חיסוני
Template:WH
Template:WS